Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
Friedrich Wimazal, Peter Valent(Medical University of Vienna), John-Hendrik Jordan(University of Vienna), Christa Fonatsch(Medical University of Vienna), Ilse Schwarzinger(Vienna General Hospital), Wolfgang R. Sperr(Medical University of Vienna), Klaus Geißler(University of Vienna), Petra Meidlinger(University of Vienna), Michael Kundi(Medical University of Vienna), Klaus Lechner, Renate Thalhammer-Scherrer(University of Vienna)
Cited by 43
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589